AERP	Atrial effective refractory period
AF	Atrial fibrillation
AIM2	Absent in melanoma 2
AMPK	AMP-activated protein kinase
Ang-II	Angiotensin II
ANP	Atrial natriuretic peptide
APD	Action potential duration
BNP	Brain natriuretic peptide
CASP1	Caspase-1
CLR	C-type lectin receptor
Cx40	Connexin 40
DAMPs	Damage-associated molecular patterns
ECM	Extracellular matrix
HF	Heart failure
HFmrEF	Heart failure with mildly reduced ejection fraction
HFpEF	Heart failure with preserved ejection fraction
HFrEF	Heart failure with reduced ejection fraction
ICa,L	L-type calcium current
IK1	Inward rectifier potassium current
IL-18	Interleukin-18
IL-1β	Interleukin-1 beta
IL-6	Interleukin-6
INa	Sodium current
LA	Left atrium
LV	Left ventricle
LVEF	Left ventricular ejection fraction
MAPK	Mitogen-activated protein kinase
NF-κB	Nuclear factor kappa-B
NLR	NOD-like receptor
PAMPs	Pathogen-associated molecular patterns
PRR	Pattern recognition receptor
RA	Right atrium
RAAS	Renin–angiotensin–aldosterone system
RIG-I	Retinoic acid-inducible gene I
ROS	Reactive oxygen species
RyR2	Ryanodine receptor type 2
TGF-β	Transforming growth factor-beta
TLR	Toll-like receptor
TNF-α	Tumor necrosis factor-alpha